Danaher Co. (NYSE:DHR) Shares Purchased by Thematics Asset Management

Thematics Asset Management lifted its holdings in Danaher Co. (NYSE:DHR) by 16.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 73,496 shares of the conglomerate’s stock after purchasing an additional 10,234 shares during the period. Thematics Asset Management’s holdings in Danaher were worth $16,871,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher during the 4th quarter worth about $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher in the fourth quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its stake in Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DHR. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Scotiabank assumed coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Wells Fargo & Company decreased their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, Barclays raised Danaher from an “equal weight” rating to an “overweight” rating and reduced their price objective for the company from $240.00 to $205.00 in a research report on Thursday, April 10th. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $274.55.

Danaher Trading Down 2.1 %

Shares of NYSE:DHR opened at $186.71 on Friday. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market cap of $133.44 billion, a P/E ratio of 35.36, a P/E/G ratio of 2.66 and a beta of 0.86. The stock’s 50-day moving average is $201.99 and its 200-day moving average is $226.91.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. Equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.69%. Danaher’s dividend payout ratio (DPR) is 24.24%.

Insiders Place Their Bets

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.